Press release
Post Bariatric Hypoglycemia Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts
To Know in detail about the Post Bariatric Hypoglycemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Post Bariatric Hypoglycemia Market Forecast
https://www.delveinsight.com/sample-request/post-bariatric-hypoglycemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Post Bariatric Hypoglycemia Market Report:
• The Post Bariatric Hypoglycemia market size was valued ~USD 200 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In January 2025, MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company specializing in precision peptide therapies for endocrine and metabolic disorders, announced positive Phase 1 results from its single and multiple ascending dose (SAD/MAD) trial of MBX 1416 in healthy adults. MBX 1416, an investigational long-acting GLP-1 receptor antagonist, is being developed as a potential treatment for Post-Bariatric Hypoglycemia (PBH).
• In November 2024, MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company specializing in innovative precision peptide therapies for endocrine and metabolic disorders, has announced the completion of the final subject's last visit in its Phase 1 trial. The study, which included single and multiple ascending doses, evaluated MBX 1416, the company's long-acting glucagon-like peptide 1 (GLP-1) receptor antagonist, being developed to treat post-bariatric hypoglycemia (PBH).
• Among the emerging treatments, Eiger BioPharmaceuticals' AVEXITIDE is projected to achieve the largest market size during the forecast period (2024-2034).
• In 2023, the total number of postbariatric hypoglycemia cases across the 7MM was estimated at around 110,000, and according to DelveInsight's projections, this number is expected to rise by 2034.
• In 2023, the US represented the largest share of postbariatric hypoglycemia cases, accounting for approximately 80% of the total cases.
• According to DelveInsight's analysis, in 2023, sleeve gastrectomy cases had the highest incidence of postbariatric hypoglycemia in the US, followed by Roux-en-Y gastric bypass cases, with other surgical approaches showing fewer cases.
• In 2023, over 90% of postbariatric hypoglycemia cases in the United States were classified as mild to moderate in severity.
• In 2023, approximately 50,000 cases of postbariatric hypoglycemia were treated in the United States.
• Key Post Bariatric Hypoglycemia Companies: RECORDATI GROUP, Xeris Pharmaceuticals, Eiger BioPharmaceuticals, Zealand Pharma, Vogenx, Inc., and others
• Key Post Bariatric Hypoglycemia Therapies: Pasireotide Diaspartate, glucagon, Lyo avexitide, Dasiglucagon, Mizagliflozin, G-PumpTM (glucagon infusion), Avexitide, and others
• The Post Bariatric Hypoglycemia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Post Bariatric Hypoglycemia pipeline products will significantly revolutionize the Post Bariatric Hypoglycemia market dynamics.
Post Bariatric Hypoglycemia Overview
Post-bariatric hypoglycemia (PBH) is a condition that can occur after weight loss surgery, also known as bariatric surgery. This condition involves episodes of low blood sugar (hypoglycemia) that typically happen one to three hours after eating. Post-bariatric hypoglycemia is more commonly associated with certain types of weight loss procedures, such as gastric bypass surgery.
Get a Free sample for the Post Bariatric Hypoglycemia Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/post-bariatric-hypoglycemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Post Bariatric Hypoglycemia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Post Bariatric Hypoglycemia Epidemiology Segmentation:
The Post Bariatric Hypoglycemia market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Post Bariatric Hypoglycemia
• Prevalent Cases of Post Bariatric Hypoglycemia by severity
• Gender-specific Prevalence of Post Bariatric Hypoglycemia
• Diagnosed Cases of Episodic and Chronic Post Bariatric Hypoglycemia
Download the report to understand which factors are driving Post Bariatric Hypoglycemia epidemiology trends @ Post Bariatric Hypoglycemia Epidemiology Forecast
https://www.delveinsight.com/sample-request/post-bariatric-hypoglycemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Post Bariatric Hypoglycemia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Post Bariatric Hypoglycemia market or expected to get launched during the study period. The analysis covers Post Bariatric Hypoglycemia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Post Bariatric Hypoglycemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Post Bariatric Hypoglycemia Therapies and Key Companies
• Pasireotide Diaspartate: RECORDATI GROUP
• glucagon: Xeris Pharmaceuticals
• Lyo avexitide: Eiger BioPharmaceuticals
• Dasiglucagon: Zealand Pharma
• Mizagliflozin: Vogenx, Inc.
• G-PumpTM (glucagon infusion): Xeris Pharmaceuticals
• Avexitide: Eiger BioPharmaceuticals
Discover more about therapies set to grab major Post Bariatric Hypoglycemia market share @ Post Bariatric Hypoglycemia Treatment Landscape
https://www.delveinsight.com/sample-request/post-bariatric-hypoglycemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Post Bariatric Hypoglycemia Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Post Bariatric Hypoglycemia Companies: RECORDATI GROUP, Xeris Pharmaceuticals, Eiger BioPharmaceuticals, Zealand Pharma, Vogenx, Inc., and others
• Key Post Bariatric Hypoglycemia Therapies: Pasireotide Diaspartate, glucagon, Lyo avexitide, Dasiglucagon, Mizagliflozin, G-PumpTM (glucagon infusion), Avexitide, and others
• Post Bariatric Hypoglycemia Therapeutic Assessment: Post Bariatric Hypoglycemia current marketed and Post Bariatric Hypoglycemia emerging therapies
• Post Bariatric Hypoglycemia Market Dynamics: Post Bariatric Hypoglycemia market drivers and Post Bariatric Hypoglycemia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Post Bariatric Hypoglycemia Unmet Needs, KOL's views, Analyst's views, Post Bariatric Hypoglycemia Market Access and Reimbursement
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Post Bariatric Hypoglycemia Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts here
News-ID: 4212624 • Views: …
More Releases from DelveInsight Business Research
Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by …
In 2023, the Limbal Stem Cell Deficiency (LSCD) market was dominated by the United States, generating nearly USD 1.5 billion in revenue, while Spain represented the smallest market with approximately USD 127 million. This regional distribution is expected to remain consistent throughout the forecast timeline. The US accounted for nearly 103,000 diagnosed LSCD cases, whereas Japan recorded around 37,000 cases, with both countries projected to witness notable growth in patient…
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Ther …
The major players operating in the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market include Roche, Prometheus Biosciences, Inc., Merck, GlaxoSmithKline, Genentech, Inc., Acceleron, Boehringer Ingelheim, Actelion, Hôpital Claude-Huriez, Changchun GeneScience Pharmaceutical, among others.
DelveInsight's report titled "Systemic Sclerosis-associated Interstitial Lung Disease Market Insights, Epidemiology, and Forecast-2034" delivers a comprehensive analysis of SSc-ILD, covering historical data, projected epidemiology, and evolving market trends across the United States, EU4 (Germany, Spain, Italy, and France),…
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerat …
The Developmental and Epileptic Encephalopathy (DEE) treatment market across the seven major markets (7MM) was valued at nearly USD 2.1 billion in 2023 and is expected to register a healthy compound annual growth rate over the forecast period. The United States emerged as the largest contributor, capturing close to 80% of the overall market revenue.
The DEE treatment landscape is undergoing a significant transformation as the limitations of traditional antiepileptic drugs…
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Co …
DelveInsight's "Polycythemia Vera Pipeline Insight 2025" report delivers an in-depth overview of the Polycythemia Vera pipeline landscape, covering more than 8 companies and 10+ pipeline candidates. The report analyzes both clinical-stage and preclinical assets, offering detailed drug profiles across various stages of development. It also evaluates Polycythemia Vera therapies based on product classification, development stage, route of administration, and molecular category, while additionally spotlighting inactive or discontinued pipeline assets.
Explore the…
More Releases for Post
Post-Tensioning System Market Next Big Thing | Major Giants Freyssinet, Suncoast …
Latest added Post-Tensioning System Market research study by AMA Research offers detailed outlook and elaborates market review till 2026. The market Study is segmented by key regions that are accelerating the marketization. At present, the market players are strategizing and overcoming challenges of current scenario; some of the key players in the study are VSL International Ltd. (Switzerland), Freyssinet (France), DYWIDAG-Systems International (Germany), Suncoast Post-Tension (United States), SRG Limited (Australia),…
Postal Operators Market Future Outlook to 2025: USPS, Japan Post, Deutsche Post, …
Research for Market in this report on the Global Postal Operators Market will continue to be interested in CAGR growth by providing an in-depth look at how major players and brands are driving the Postal Operators Market during the 2019-2025 forecast period.
In addition, the Postal Operators Market definition, classification, application and participation of the Global Postal Operators Market was described. The Global Postal Operators Market is categorized by market…
Postal Operators Market Future Outlook to 2025: USPS, Japan Post, Deutsche Post, …
Research For Market in this report on Global Postal Operators Market will keep you apprised in this CAGR growing market by letting you know in-depth how the key players and brands are driving the market in the forecast period of 2019-2025.
Further, the markets definition, classifications, applications, and engagements in the Global Postal Operators Market have been described. The Global Postal Operators Market has been classified according to market size…
Parcel Delivery Market Wide Spread Across the World | China Post, Deutsche Post …
HTF MI recently introduced Global Parcel Delivery Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are China Post, Deutsche Post DHL, FedEx, Japan Post Group, La Poste…
E Commerce Logistics Market Outlook 2023 – FedEx, Australia Post, Blue Dart, C …
E-commerce is the activity of buying or selling of products on online services or over the Internet.
There are many factors that augment the growth of global E commerce logistics market such as growing E commerce market, smaller and simple supply chain, new and innovative methods of deliveries and so on.
The report comprises the study of the global e-commerce logistics market that focuses on various types of services in the market.…
Parcel Delivery Market is Booming Worldwide | Deutsche Post DHL, FedEx, Japan Po …
HTF MI recently introduced Global Parcel Delivery Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are China Post, Deutsche Post DHL, FedEx, Japan Post Group, La Poste…
